Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cerus Corp (CERS)  
$1.85 0.10 (5.13%) as of 4:30 Tue 5/21


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 167,140,000
Market Cap: 309.21(M)
Last Volume: 875,083 Avg Vol: 1,600,057
52 Week Range: $1.25 - $3.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 7.6
Insider 6 Months    : 8.6
Insider 3/6 Months : 16
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cerus is a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The INTERCEPT Blood System, which is based on Co.'s technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Co.'s INTERCEPT Blood System is intented for use with blood components including platelets, plasma and red blood cells. Co. has received U.S. Food and Drug Administration approval for the INTERCEPT Blood System for Cryoprecipitation, which uses Co.'s plasma system to produce INTERCEPT Fibrinogen Complex for the treatment and control of bleeding.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 27,000 37,000 74,350 74,350
Total Buy Value $51,042 $67,242 $136,547 $136,547
Total People Bought 4 5 7 7
Total Buy Transactions 4 5 10 10
Total Shares Sold 370,345 370,345 370,345 575,085
Total Sell Value $759,322 $759,322 $759,322 $1,393,255
Total People Sold 7 7 7 8
Total Sell Transactions 14 14 14 24
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 407
  Page 1 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shan Hua Director   –       •      –    2024-05-13 4 B $1.99 $4,975 D/D 2,500 32,386 2.31 -2%     
   Nachtsheim Jami K Director   –       •      –    2024-05-10 4 B $1.79 $3,578 D/D 2,000 108,362 2.31 14%     
   Witney Frank Director   –       •      –    2024-05-09 4 B $1.89 $37,800 D/D 20,000 180,059 2.39 3%     
   Swisher Daniel N Jr Director   –       •      –    2024-05-09 4 B $1.88 $4,689 D/D 2,500 107,045 2.31 3%     
   Menard Chrystal Chief Legal Officer   •       –      –    2024-03-14 4 AS $1.97 $35,192 D/D (17,824) 490,912 -1%     
   Corash Laurence M Chief Scientific Officer   •       –      –    2024-03-14 4 AS $1.97 $28,352 D/D (14,360) 2,339,740 -1%     
   Greenman William Mariner President and CEO   •       •      –    2024-03-14 4 AS $2.02 $128,195 D/D (63,611) 3,181,281 -1%     
   Benjamin Richard J Chief Medical Officer   •       –      –    2024-03-14 4 AS $1.97 $35,022 D/D (17,738) 459,612 -1%     
   Green Kevin Dennis Chief Financial Officer   •       –      –    2024-03-14 4 AS $1.97 $42,444 D/D (21,497) 618,750 -1%     
   Jayaraman Vivek K Chief Operating Officer   •       –      –    2024-03-14 4 AS $1.97 $52,902 D/D (26,794) 878,653 -1%     
   Menard Chrystal Chief Legal Officer   •       –      –    2024-03-13 4 AS $2.06 $35,915 D/D (17,460) 508,736 -3%     
   Corash Laurence M Chief Scientific Officer   •       –      –    2024-03-13 4 AS $2.06 $28,936 D/D (14,067) 2,354,100 -3%     
   Greenman William Mariner President and CEO   •       •      –    2024-03-13 4 AS $2.06 $128,182 D/D (62,315) 3,244,892 -3%     
   Benjamin Richard J Chief Medical Officer   •       –      –    2024-03-13 4 AS $2.06 $35,744 D/D (17,377) 477,350 -3%     
   Green Kevin Dennis Chief Financial Officer   •       –      –    2024-03-13 4 AS $2.02 $42,438 D/D (21,058) 640,247 -3%     
   Moore Carol SVP Reg. & Quality   •       –      –    2024-03-13 4 AS $1.97 $41,553 D/D (20,619) 490,623 -3%     
   Jayaraman Vivek K Chief Operating Officer   •       –      –    2024-03-13 4 AS $2.06 $53,990 D/D (26,247) 905,447 -3%     
   Menard Chrystal Chief Legal Officer   •       –      –    2024-03-12 4 OE $0.00 $0 D/D 16,666 526,196     -
   Corash Laurence M Chief Scientific Officer   •       –      –    2024-03-12 4 OE $0.00 $0 D/D 16,666 2,368,167     -
   Greenman William Mariner President and CEO   •       •      –    2024-03-12 4 OE $0.00 $0 D/D 64,666 3,307,207     -
   Benjamin Richard J Chief Medical Officer   •       –      –    2024-03-12 4 OE $0.00 $0 D/D 16,666 494,727     -
   Green Kevin Dennis Chief Financial Officer   •       –      –    2024-03-12 4 OE $0.00 $0 D/D 21,666 661,305     -
   Moore Carol SVP Reg. & Quality   •       –      –    2024-03-12 4 OE $0.00 $0 D/D 11,666 511,242     -
   Jayaraman Vivek K Chief Operating Officer   •       –      –    2024-03-12 4 OE $0.00 $0 D/D 25,000 931,694     -
   Benjamin Richard J Chief Medical Officer   •       –      –    2024-03-08 4 AS $2.40 $70,457 D/D (29,378) 478,061 -13%     
  407 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us